Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves

Information

  • Patent Grant
  • 9744037
  • Patent Number
    9,744,037
  • Date Filed
    Friday, March 14, 2014
    10 years ago
  • Date Issued
    Tuesday, August 29, 2017
    7 years ago
Abstract
Improved catheter devices for delivery, repositioning and/or percutaneous retrieval of percutaneously implanted heart valves are described, including a medical device handle that provides an array of features helpful in conducting a percutaneous heart valve implantation procedure while variously enabling radial expansion or contraction and/or lateral positioning control over the heart valve during the medical procedure.
Description
FIELD

The embodiments described herein relate to delivery systems for percutaneously delivered heart valves.


BACKGROUND

Correct valve positioning is crucial for treatment success and optimal outcomes after transcatheter valve implantation. For example, to maintain a stable and correct lengthwise position with respect to the aortic annulus, a stepwise deployment that allows the valve to be repositioned both circumferentially and in the axial direction (i.e., towards the left ventricle (LV) or the ascending aorta) is important.


However, most of the current technologies are limited by instant deployment, and once the valve is deployed, repositioning and/or percutaneous retrieval is not possible—or at least difficult or potentially problematic. Placement of a stented valve in a position that is too high (or proximal) can totally or partially obstruct the coronary ostia in a case of aortic implantation, which may result in myocardial infarction or ischemia. Additionally, if the valve is placed too high in the aorta, it may embolize into the aorta causing significant paravalvular regurgitation. On the other hand, implantation in a position that is too low (or distal) is accompanied by compression of the atrioventricular (AV) node in the membranous septum, which leads to conduction abnormalities.


Further technical developments with a focus on a positionable, repositionable, and/or percutaneously retrievable valve design would allow optimal placement and may thereby significantly reduce the risk of paravalvular aortic regurgitation, myocardial infarction, or ischemia related to improper positioning.


SUMMARY

Embodiments described herein address the need for improved catheter devices for delivery, repositioning and/or percutaneous retrieval of percutaneously implanted heart valves. Features of a medical device handle are described that provide an array of features helpful in conducting a percutaneous heart valve implantation procedure while variously enabling radial expansion or contraction and/or lateral positioning control over the heart valve during the medical procedure.


The subject delivery devices, kits in which they are included (with and without valve installation or assembly), methods of use and manufacture (such as assembly of the delivery system and frame alone and/or with included valve) are all included within the scope of the present disclosure. Some aspects of the same are described above; more detailed discussion is presented in connection with the figures below.


Other systems, devices, methods, features, and/or advantages of the subject matter described herein will be or will become apparent to one with skill in the art upon examination of the following figures and detailed description. It is intended that all such additional systems, devices, methods, features, and/or advantages be included within this description and be within the scope of the subject matter described herein, regardless of whether recited in this summary section. In no way should the features of the example embodiments in this or any other section be construed as limiting the appended claims, absent express recitation of those features in the claims.





BRIEF DESCRIPTION OF THE DRAWINGS

The details of the subject matter set forth herein, both as to its structure and operation, may be apparent by study of the accompanying figures, in which like reference numerals refer to like parts. The components in the figures are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the subject matter. Moreover, all illustrations are intended to convey concepts, where relative sizes, shapes and other detailed attributes may be illustrated schematically rather than literally or precisely. Variations other than those shown in the figures are contemplated as described in a broader sense in the above summary section, as generically claimed, or otherwise.



FIGS. 1A-1F are perspective views illustrating an example embodiment of a stent frame and valve in various stages of deployment as may be employed in connection with the embodiments herein.



FIG. 2A is a detail view illustrating the delivery device sleeve of a first embodiment showing the location of one of a plurality of embedded arms; FIG. 2B is a detail view illustrating the arm at the location in FIG. 2A connected to a spring system for controlling stent frame deployment.



FIG. 3 is a system overview illustrating the arms releasably attached to a stent frame.



FIG. 4A is a detail view illustrating the arms fully extended from the delivery apparatus and FIG. 4B is a detail view illustrating a hollow deployment arm with strings inside and a pull/push mechanism inside the guide tube or sleeve.



FIGS. 5A-5E illustrate progressive stages of stent frame deployment and recapture for a second embodiment.



FIGS. 6A-6C illustrate side, end, and perspective views, respectively, of the delivery device sleeve of the second embodiment.



FIGS. 7A and 7B are side views illustrating the sent frame associated with the delivery device sleeve in contracted and expanded states, respectively.



FIG. 8A illustrates a variation of the subject stent frame and FIG. 8B illustrates a variation of the subject delivery sleeve with associated draw line filaments.



FIGS. 9A-9C are side, perspective, and end views, respectively, illustrating the components in FIGS. 8A and 8B assembled together.



FIGS. 10A and 10B are side and end views, respectively, illustrating the same assembled components shown in a compressed state.



FIGS. 11A and 11B are partial perspective and detail side views, respectively, illustrating a stent frame for a third embodiment.



FIG. 12 is a perspective view illustrating a frame retainer with retainer fingers.



FIGS. 13A and 13B are perspective and end views, respectively, illustrating a zip tube part or assembly and zip tube fingers.



FIG. 14A illustrates segments of an expanded heart valve frame, retainer fingers, and zip tube fingers as associated in the subject embodiment and FIG. 14B illustrates a complete assembly of the embodiment including these subcomponents.



FIGS. 15A-15F are detail side views illustrating operation of elements within the FIGS. 14A and 14B embodiment.



FIG. 16 is an enlarged perspective view of a stent frame component as previously illustrated.



FIGS. 17A and 17B are side views illustrating the stent frame embodiment of FIG. 16 associated with a delivery device, with the stent frame in a neutral and a laterally displaced position, respectively.



FIGS. 18A and 18B are photographs illustrating prototype hardware of the delivery system embodiment diagrammatically illustrated in FIGS. 17A and 17B.



FIG. 19 diagrammatically illustrates an alternative user interface for the FIGS. 17A and 17B delivery system.



FIG. 20 is a cross-section view of a full medical device handle incorporating features related to those in FIGS. 17A-18B.





DETAILED DESCRIPTION

Various example embodiments are described below. Reference is made to these examples in a non-limiting sense, as it should be noted that they are provided to illustrate more broadly applicable aspects of the devices, systems and methods. Various changes may be made to these embodiments and equivalents may be substituted without departing from the true spirit and scope of the various embodiments. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, process, process act, or step to the objective(s), spirit, or scope of the present inventive subject matter. All such modifications are intended to be within the scope of the claims made herein.



FIGS. 1A-1F illustrate an implant 2 and a suitable approach to valve 10 attachment and its manipulation for delivery in coordinated use with an expandable stent frame 20. Further details as to valve construction and/or its manipulation for delivery may be appreciated in review of U.S. Pat. No. 8,133,270 to Kheradvar, et al., incorporated by reference herein in its entirety for all purposes. Features of the stent frame elaborated upon below in the various embodiments may be added to those shown in FIGS. 1A-1F or used in connection with other suitable stent frame and/or other valve architectures.


In any case, implant 2 (e.g., valve 10 and stent frame 20) is directly applicable for coordinated use with a delivery system as shown in FIGS. 2A-4B. More specifically, a delivery system apparatus for controlled deployment of a stented heart valve system in increments is shown. The system provides for repositioning a stented heart valve system during and after deployment. As variously illustrated, device 100 includes a plurality of deployable arms 110. These are adjustably deployable. The arms are first embedded inside the apparatus. FIG. 2B illustrates the location of one of the embedded arms 110 within a delivery device sleeve 120. For tracking to the target site, the arms are hidden. The arms exit the sleeve through ports or slots 122 in the wall of the sleeve. The arm lengths are adjustable and the arms are releasably attached to the stent of the stented valve. As shown in FIG. 2B, each arm may be equipped with an in-line adjustable spring that is controllable by the operator remotely. As illustrated in FIG. 3, such actuation allows for robust radial expansion or deployment of the collapsed stent frame in increments.


The arms remain attached to the stent until the stent is fully deployed. During tracking to a site for deployment, the stented valve may be covered by a sheath incorporated in the delivery system or pass within a delivery catheter (either case illustrated by an optional sleeve 140). If the stent is not properly deployed, the arms, which are still releasably attached to the stent, can be used for partial contraction of the stent for repositioning purposes. When the stented valve is properly positioned within the heart, the arms will be released from the stent, and return to their embedded positions within the apparatus. Then the apparatus will be retracted into the sheath or through the delivery catheter from the heart or vasculature.


As seen in FIG. 4A in which the stent frame is detached, each arm may terminate in a releasable hook, jaw, clevis 112 or the like for such purpose(s). The connection and release may be provided by a simple snap fit. Otherwise it may be provided by a more active means for stent frame interface as illustrated in FIG. 4B, that shows an arm comprising a hollow micro tube or sheath 114 with spring loaded strings or filaments 116 inside where a string or filament 118 inside the guide tube or sleeve 120 can be used to control the closing and opening of the hooks 112.



FIGS. 5A-5E illustrate progressive stages of implant deployment and recapture for a second embodiment. Here, in a system pictured for over-the-wire tracking to its deployment site, a delivery system 200 includes a sheath 210 (with distal radiopaque marker 212) coaxial with a pusher sleeve 220. A distal portion of sleeve 220 includes apertures 222 through which filaments 230 pass into and proximally within the length of the sleeve. The filaments loop from these apertures through proximal stent frame apertures 22 and more distal stent frame apertures 24 (or alternatively past strut junctions in a different stent configuration) and into a distal end 224 of the sleeve (or a second set of distal apertures (not shown) in the sleeve if so-desired). Such details of the sleeve are shown unobscured in FIGS. 6A-6C, as is an optional shoulder 226 for abutting proximal end or crown sections 26 of the stent frame and guide sheath 210 of the proximal end or crowns of the stent frame.


Regarding interaction between the stent frame and delivery system 200, FIGS. 7A and 7B provide side views of the stent frame associated with the delivery device sleeve in contracted and expanded states, respectively. Here, the manner of stent frame expansion and contraction as related to extended filament 230 length is clearly visible.



FIGS. 8A and 8B further illustrate such details as described above. When assembled in a delivery system 200, stent frame 20 will be captured within loops 232. The assembled relation of elements is shown in each of FIGS. 9A-9C and FIGS. 10A and 10B. Comparing FIGS. 9A-9C to FIGS. 10A and 10B, the state of the stent frame is changed from open or expanded in the former trio of figures, to compressed in the latter pair.


Such control is achievable by remote actuation of the loop filaments with a customized handle (e.g., as further described below) or other user interface means. Any handle may include means for group control of the filaments and independent control of sheath position. Such a handle 240 may include separate “grip” 242 and “plunger” or “slide” 244 interfaces as illustrated by example in FIG. 9A for such purposes. Otherwise, mechanism internal to the handle can automate all of the various control procedure(s) by actuating a grip 242, alone.



FIGS. 9A and 9B also offer good illustration of the manner in which filaments 230 pass through apertures 22, 24 and run along interposed strut sections 28. FIG. 9C illustrates the radial relationship of the apertures and filament 230 portions. Here, a crossing segment 234 of the filament between the apertures 22 and 24 is positioned outside of and opposing strut section 28. The crossing segments are angled with the struts when the stent frame is in an expanded state and more close to axially aligned when the stent is compressed as shown in FIGS. 10A and 10B.


As noted above, the transition between the open and compressed states (and states there between) is managed by letting-out or reeling-in the draw line filament determining the size of the control loop. Ultimately, one end of the line is pulled all of the way through the stent aperture to finally release the implant.



FIGS. 5A-5E illustrate a range of activity that is possible in terms of device manipulation before such release. In succession, these views show progressive stent frame deployment and steps toward complete recapture. FIG. 5A pictures (literally, given that the figures are based on photographs) the beginning of stent frame deployment as sheath 210 is withdrawn and a distal end 30 of the stent self-expands. FIG. 5B shows the sheath fully withdrawn and full tension on the draw lines or filaments, maintaining a proximal side 32 of the stent 20 in a compressed state. As in FIG. 5D illustrating the same (but in the case of FIG. 5D re-compression after the relaxation of draw lines to allow expansion as in FIG. 5C), the sheath can be advanced to fully recapture the stent frame. With the beginning of such action shown in FIG. 5E, the stent frame can be fully recovered within sheath 210—whether for the purpose of repositioning or bulk retrieval of the device.


A third delivery device embodiment is able to offer similar advantages in terms of delivery, repositioning, and/or percutaneous retrieval. Stent frame components of such a system are shown in FIGS. 11A and 11B. In each view, a proximal end 32 of a stent frame 20 includes clasp features 40. Each clasp feature 40 may comprise a bridge section 42 and an overhang section 44. Complementary clasp features 50 are provided at the end of resilient retainer “arms” or “fingers” 52 associated with a delivery system pusher. Arms 52 may comprise Nitinol or another elastic or superelastic material. Arms 52 are biased outward such that they spring out to a position as shown in FIG. 12 when released from restraint (e.g., upon exiting a delivery system sheath element or delivery/guide catheter body). Arms 52 are joined or meet at a hub 54. These components may be cut from a single hypotube or polymer sleeve that extends to the proximal end of the delivery system (not shown) as one piece or be assembled using conventional techniques such as laser welding, etc. In any case, pairs of complementary clasp elements 40/50 are releasably engaged in sheaths 60.



FIGS. 13A and 13B illustrate a construct in which multiple sheaths 60 extend to and join at a hub 62 optionally extending proximally as a single sleeve 64. Such a structure can be produced by bundling and reconfiguring (e.g., by fusing) a plurality of thermoplastic sheaths, bundling and bonding a plurality of sheaths, and splitting an end of a multi-lumen extrusion into a plurality of separate sheaths. Other means of construction will be appreciated by those of skill in the art as well.


Regardless, FIG. 14A provides a partial assembly drawing illustrating the axial alignment for a plurality of interfacing members. FIG. 14B shows the same components of the third device embodiment brought together in a completed apparatus assembly 300. As in the embodiments above, such a system may optionally include a cover sheath 210 and a handle 240. In addition, system 300 may include an innermost elongate sleeve 220′ optionally providing a lubricious PTFE liner for a guidewire lumen and/or column or “push” strength to the system.



FIGS. 15A-15F illustrate the operation of an intended interaction of the subcomponents of system 300. In FIG. 15A, the heart valve frame clasp or link 40 is interfaced with clasp/line 50. In FIG. 15B, clasps features 40/50 are trapped within sheath 60. At this point, further withdrawal of stent frame 20 into sheath element 60 or (stated otherwise) advancement of sheath 60 over adjacent proximal stent struts 34 results in a condition as shown in FIG. 15C. Here, struts 34 are brought together collapsing the entirety of the proximal end 32 of stent frame 20 (given that the same condition is achieved around the entire periphery of the stent by paired device features). As shown in FIG. 15D, sheath 60 can cover the entirety of struts 34 up to their junctions 36 with adjacent struts. The net effect is shown in FIG. 15E where the entire proximal side of the stent frame 20 is compressed efficiently by the multiple sheath elements shown.


As summarized above, the zip tube part assembly (sheaths 60 and associated components) may be variably retracted to allow the proximal end 32 of the stent frame to partially expand or retracted sufficiently to allow the stent frame to fully expand. Alternatively, the zip part/assembly may be secured in position and the arm retainer 54 retracted to variably collapse the proximal end of the heart valve device (up to fully collapsed) or variably advanced to allow the self-expanding heart valve device to variably expand (up to fully expanded). Further action associated with collapse/compression and expansion of the stent frame is achieved by covering and uncovering the stent frame with optional sheath 210 or by a guide catheter. Upon achieving desired implant placement, clasp elements 40/50 can be freed from confinement within the sheath member(s) 60 thereby unlinking the elements allowing stent frame 20 release as shown in FIG. 15F and allowing delivery system withdrawal from a patient in a successful percutaneous heart valve implantation procedure.



FIG. 16 is a perspective view of a stent frame 20 component that may be employed herein. Actually, this figure provides an enlarged view of the stent frame shown in FIGS. 7A and 7B. So-enlarged, features in addition to those of the stent in U.S. Pat. No. 8,133,270 upon which the overall architecture may be based are easily highlighted. Specifically, two sets of holes 22 and 24 (proximal and more distal) are provided at the proximal side 32 of the stent frame 20 (i.e., on the “top” of the stent that would be positioned in the aortic root). These holes allow for passage of a network of pull-strings or filaments used for step-wise deployment, repositioning of the stent, and retrievability back to the guide-wire catheter (as discussed above) and also lateral positioning (as discussed below). Further, T-shaped structures 4 at the proximal side 32 are added to proximal crown features 26 to accommodate repositioning and retrievability of the valve during implantation procedure by way of attachment to complimentary delivery system features 40 like the example shown in FIGS. 14A and 14B.


In addition, connector holes 6 in tabs 8 of material at the middle of a number of struts 28 are provided to accommodate locking with pin-shape structures that permanently affix/connect the valve 10 material to the stent frame structure as further described in U.S. patent application Ser. No. 13/773,389 filed Feb. 21, 2013, which application is incorporated by reference herein in its entirety. A set of distal holes 12 at distal end 30 or “bottom” ventricular side of the stent advantageously provide attachment points (e.g., by suturing) of the valve leaflets to the stent frame as illustrated in FIGS. 1A-1F.



FIGS. 17A and 17B are side views of the same stent frame 20 associated with a delivery system 200′ related to that in FIGS. 5A-10B, but including additional manipulation features. Specifically, delivery system 200′ is adapted for controlling the lateral position of a heart valve device, for positioning or repositioning during deployment. Draw lines (or filaments) 230 configured as in the referenced embodiments are further connected to a pivot fitment 250 and a joystick-type handle 252.


As shown in FIGS. 18A and 18B, loops or end ties 236 around spurs 256 may provide such a connection. As likewise shown, fitment 250 (alternatively, a boss, cap or housing) may ride upon or otherwise incorporate one or more spherical bearing surfaces 254/254′.


However configured, operation of system 200′ is such that the angular ordering of the draw lines 230 in the overall heart valve (stent frame 20 shown) will correspond to the angular ordering of the draw lines on pivot fitment 250. Such activity is assured by the corresponding relationship of draw lines (or filaments) as shown in cross-sections A-A and B-B in FIG. 17A. The radial orientation of filaments 230 at the stent frame 20 and leading to the stent frame are matched with the radial orientation of the filaments at fitment 250 is indicated by the matching numeral position in the two cross-sectional views.


Therefore, as shown in FIG. 17B, tilting the pivot fitment 250 (e.g., by lever arm/joystick 252) causes coordinated pull and release (or relaxation) of the draw lines proportional to the angular ordering and the direction of tilt to drive a corresponding change in the lateral position of the heart valve device (denoted by the directional arrows). Thus, the lateral position of the heart valve device can be controlled and manipulated by tilting the pivot fitment. While a joystick or similar interface can be incorporated into or connected to the pivot fitment to facilitate control of the tilt mechanism, other approaches including remote/robotic control are contemplated as well and may be integrated into or with the handle system or its features as further described below.


Regarding intended system operation, FIGS. 18A and 18B are photographs of a functional prototype 200″ of the delivery system embodiment diagrammatically shown in FIGS. 17A and 17B. Here, blocks 260, 262 simulate the end constraint conditions of a catheter body. Between these, filaments 230 are visible (whereas they would generally be housed within a catheter body/sleeve). A short sleeve 264 extends from block 262 to simulate the distal portion of the catheter body 220 shown in FIGS. 5A-10B, 17A and 17B including its side apertures 222 and an end hole 224.


In FIG. 18A, stent frame 20 and pivot fitment 250 are shown in a neutral or “home” position. While being tilted/turned, as shown in FIG. 18B, pivot fitment 250 reorients the filaments 230 to move stent 20 laterally in relation to sleeve 264.



FIG. 19 diagrammatically illustrates an alternative user interface for the FIGS. 17A and 17B delivery system. Here, instead of using a handle, a model 260 of the implant 2 (or at least the stent frame 20) to be delivered is employed. The model may be a scale replica of the stent frame 20 and/or the entire implant 2. Generally, it will be configured in an expanded shape. However, it may be controlled so that its state of expansion matches that of implant 2. Alternatively, manipulation of the model expansion may alter the expansion state of the implant.


Given all of these options, however, the model will generally at least serve as an interface for lateral valve positioning. In which case, the model may be connected to the filaments in the same manner/fashion as the stent frame 20 to be manipulated along a catheter centerline 270 by movement of the model in any combination of lateral directions indicated by the axis arrows shown. Alternatively, model 260 may overlay and be connected to fitment 250 to which the filaments are connected (e.g., at spurs 254).


Use of the model 260 in manipulating the stent frame 20 and being able to visualize the direct correspondence of movement between the implant (via fluoroscopy or other medical imaging) to the sight of the model in hand may be particularly beneficial to a physician in attempting ideal implant positioning and placement. In a method of use, the method may comprise at least partially deploying stent frame 20 by withdrawing a sheath 210 covering the stent frame and relaxing the filaments 230 passing through a catheter sleeve 220 and attached to the stent frame to expand the stent frame (e.g., as in such activity shown in FIGS. 5A-5C). Then, a proximal interface such as a joystick or model is manipulated to move the stent frame laterally relative to the catheter sleeve by selectively tightening and relaxing the filaments (e.g., as in such activity shown in FIG. 17B relative to a zero or neutral position of fitment 252). Naturally, the device can be returned to center and then recompressed and/or re-sheathed for repositioning as well.



FIG. 20 illustrates another interface option. The figure provides a cross-sectional view of a full medical device handle 400 incorporating features related to those discussed above in connection with FIGS. 17A-18B. Notably, handle 400 or features therein may be adapted or otherwise employed in connection with previously-described embodiments or interface features as well.


In any case, handle 400 is shown with an elongate body 402 for structural support of handle components and passage of stent lines 230 (variously pictured above, with one line shown in FIG. 20) optionally defining twelve loops 232 capturing a stent frame (again, as pictured above) through a central lumen 404 of the device. Slots 406 through which the lines are passed guide or fix their rotational orientation. The handle may include a catheter hub 410 with a catheter attachment interface 412 and a flushing port 414. A proximal wire port 420 may provide for flushing and/or guidewire access. Additional features include V-ports 430, a stripper ring 440, a side lock 450, and a pivot ring fitment 250 riding on a section of a spherical bearing 254.


In use, stent lines 230 (and the loops 232 that they define) are positioned through a valve and catheter as previously described, passed through handle body 402 and out of slots 406, where stent lines 230 and are attached to pivot ring 250 (per above, one representative line 230 is shown in FIG. 20). One end of each loop 232 may pass over a groove 408 in the pivot ring fitment body or a spur 256, also as described herein.


Manipulation of an attached stent frame is controlled by pivot ring 250 in two ways as indicated by the action arrows. Rotation of pivot ring 250 along an axis (see centerline indicated in FIG. 20) of the handle body 402 evenly controls the tension in the stent lines, giving control over radial expansion/contraction of the stent frame. Tilting the pivot ring relative to the handle body axis when the valve is in a deployed state shifts the lateral position of the stent relative to its delivery catheter by tensioning some lines and slackening (or letting out) others.


Slide lock 450 is adapted to releasably engage pivot ring 250 to allow or prevent its rotation (prevented with lock 450 in the proximal position and allowed with lock 450 in the central position) and to allow or prevent tilt of pivot ring 250 (allowed with lock 450 in a distal position). Slide lock 450 may be spring loaded toward the proximal position and/or manual detent features may be provided to assist in position control or inadvertent state change.


Using handle 400 in an prosthetic valve implantation procedure, various maneuvers may be desired. In one example, the valve stent frame is in a deployed state and the intent is to compress it. To do so, slide lock 450 is moved distally (to the left in the drawing to its central position) to disengage a slot (not shown) interfacing with a locking pin 452 (or splines or another anti-rotation feature). Pivot ring 250 is rotated until the stent is compressed by (in effect) winding-up the lines, and slide lock 450 is then returned to its proximal position to maintain stent compression.


In another example, the stent is in a compressed state and the intent is to release it. Here, slide lock 450 is, again, moved distally to its central position out of rotationally-locked engagement with pivot ring 250. Ring 250 is then rotated until the stent is released and slide lock 450 is moved back into pivot ring engagement to maintain the released state.


In yet another example, the stent is in a deployed state and the intent is to shift the lateral position of the stent relative to its catheter. To do so, slide lock 450 is moved to its distal-most position out of lateral engagement with socket 454 and pivot ring 250 is tilted in the desired direction to shift the stent laterally in the desired direction.


V-Ports 430 provide access for valve inversion and locking loops (i.e., with lines—not shown—defining three or more loops that may be connected to valve membrane leaflets for their inversion from a delivery configuration and then locking them in place, e.g., as with locking-pin type hardware described in U.S. patent application Ser. No. 13/773,389 (incorporated by reference above). After such valve manipulation, the locking loops are cut and pulled through the port(s) out from one end.


To facilitate external access of the lines through ports and to lower the frictional interaction between the lines and the handle body, the ports may be angled by between about 30 and about 60 degrees with respect to an axis of body 402. While pivot ring 250 provides rotational control for the state of deployment and tilt control for the lateral position (relative to catheter) of stent, it may also include a groove 408 therein providing clearance for cutting stent lines 230 to release a deployed valve. Last, stripper ring 440 provides a means to simultaneously pull all the stent lines 230 out of the stent, and catheter/handle combination after they have been cut for release.


Variations

In the various delivery system architectures, the catheter/pusher shaft or sleeve may comprise a simple extrusion (e.g., PTFE, FEP, PEEK, PI etc.) or may be constructed using conventional catheter construction techniques and include a liner, braid support and outer jacket (not shown). Likewise, the various tubular members may comprise extrusion (per above), metal hypotube, etc. Further, the stent frame may be constructed using conventional laser cutting and electropolishing techniques and/or be otherwise constructed. In embodiments intended for tracking through a guide/delivery catheter without an incorporated sheath, a loading sheath (optionally peel-away or splittable) may be provided over the implant. Other typical percutaneous access instruments (such as wires, etc.), valves, and other hardware may also be employed in connection with the subject matter described herein.


The subject methods may include each of the physician activities associated with implant positioning, re-positioning, retrieval and/or release. Regarding these methods, including methods of manufacture and use, these may be carried out in any order of events which is logically possible, as well as any recited order of events.


Furthermore, where a range of values is provided, it is understood that every intervening value, between the upper and lower limit of that range and any other stated or intervening value in the stated range is encompassed within the invention. Also, it is contemplated that any optional feature of the described variations may be set forth and claimed independently, or in combination with any one or more of the features described herein.


Reference to a singular item includes the possibility that there are a plurality of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “an,” “said,” and “the” include plural referents unless specifically stated otherwise. In other words, use of the singular forms allow for “at least one” of the subject item in the description above as well as the claims below. It is further noted that the claims may exclude any optional element and may explicitly limit each element to a “single” instance or “only one” such instance of that element. As such, this paragraph is intended to serve as antecedent basis for the use of such exclusive terminology as “solely,” “only,” “a single” and the like in connection with the recitation of claim elements, or the use of a negative limitation.


Without the use of such exclusive terminology, the terms “comprising,” “including,” and “having” in the claims shall allow for the inclusion of any additional element—irrespective of whether a given number of elements are enumerated in the claim, or the addition of a feature could be regarded as transforming the nature of an element set forth in the claims. Except as specifically defined herein, all technical and scientific terms used herein are to be given as broad a commonly understood meaning as possible while maintaining claim validity.


The breadth of the different embodiments or aspects described herein is not to be limited to the examples provided and/or the subject specification, but rather only by the scope of the issued claim language.

Claims
  • 1. A medical device handle, the handle comprising: an elongate body;a plurality of filaments, the body adapted to receive the plurality of filaments for connection to a stent frame in a radial orientation;a slide lock adapted to slide along the body;a pivot fitment connected to the plurality of filaments, the plurality of filaments spaced in a radial orientation matching the radial orientation of the plurality of filaments at the stent frame; anda spherical bearing surface,wherein the pivot fitment rides on the spherical bearing surface,wherein in a first axial position, the slide lock permits no rotation of the fitment around and no tilting of the fitment relative to an axis of the body,wherein in a second axial position, the slide lock permits rotation of the fitment around but no tilting relative to the body axis, andwherein in a third axial position, the slide lock permits tilting of the fitment relative to the axis of the body.
  • 2. The handle of claim 1, wherein in the third axial position the slide lock permits no rotation of the fitment around the axis of the body.
  • 3. The handle of claim 1, wherein the body includes a lumen for receiving the plurality of filaments.
  • 4. The handle of claim 1, further comprising a catheter hub including a flushing port.
  • 5. The handle of claim 1, wherein the body includes at least one side port.
  • 6. The handle of claim 5, wherein a plurality of side ports are provided.
  • 7. The handle of claim 1, further comprising a plurality of slots for the plurality of filaments.
  • 8. The handle of claim 1, further comprising a ring proximal to the fitment for simultaneously removing the plurality of filaments upon being cut.
  • 9. The handle of claim 1, further comprising a guidewire access port.
  • 10. The handle of claim 1, wherein the fitment includes a socket receiving the slide lock in the first and second axial positions.
RELATED APPLICATIONS

This filing claims the benefit of and priority to U.S. Provisional Patent Application Ser. No. 61/793,926, filed Mar. 15, 2013, which is incorporated by reference herein in its entirety for all purposes.

US Referenced Citations (708)
Number Name Date Kind
3153975 Rapata Oct 1964 A
3671979 Moulopoulos Jun 1972 A
4291420 Reul Sep 1981 A
4451936 Carpentier et al. Jun 1984 A
4692164 Dzemeshkevich et al. Sep 1987 A
4759758 Gabbay Jul 1988 A
4787901 Baykut Nov 1988 A
4790843 Carpentier et al. Dec 1988 A
4851001 Taheri Jul 1989 A
4872874 Taheri Oct 1989 A
4935030 Alonso Jun 1990 A
4994077 Dobben Feb 1991 A
5002567 Bona et al. Mar 1991 A
5032128 Alonso Jul 1991 A
5037434 Lane Aug 1991 A
5080668 Bolz et al. Jan 1992 A
5141491 Bowald Aug 1992 A
5163953 Vince Nov 1992 A
5219355 Parodi et al. Jun 1993 A
5254127 Wholey et al. Oct 1993 A
5282847 Trescony et al. Feb 1994 A
5327774 Nguyen et al. Jul 1994 A
5332402 Teitelbaum Jul 1994 A
5360444 Kusuhara Nov 1994 A
5370685 Stevens Dec 1994 A
5397351 Pavcnik et al. Mar 1995 A
5411552 Andersen et al. May 1995 A
5445626 Gigante Aug 1995 A
5469868 Reger Nov 1995 A
5480423 Ravenscroft et al. Jan 1996 A
5500014 Quijano et al. Mar 1996 A
5545214 Stevens Aug 1996 A
5554185 Block et al. Sep 1996 A
5571175 Vanney et al. Nov 1996 A
5591195 Taheri et al. Jan 1997 A
5607464 Trescony et al. Mar 1997 A
5609626 Quijano et al. Mar 1997 A
5643208 Parodi Jul 1997 A
5693087 Parodi Dec 1997 A
5713953 Vallana et al. Feb 1998 A
5716370 Williamson, IV et al. Feb 1998 A
5735859 Fischell et al. Apr 1998 A
5741326 Solovay Apr 1998 A
5741333 Frid Apr 1998 A
5749890 Shaknovich May 1998 A
5800506 Perouse Sep 1998 A
5824061 Quijano et al. Oct 1998 A
5824064 Taheri Oct 1998 A
5840081 Andersen et al. Nov 1998 A
5855597 Jayaraman Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5855602 Angell Jan 1999 A
5879320 Cazenave Mar 1999 A
5895419 Tweden et al. Apr 1999 A
5910170 Reimink et al. Jun 1999 A
5925063 Khosravi Jul 1999 A
5931855 Buncke Aug 1999 A
5954766 Zadno-Azizi et al. Sep 1999 A
5957949 Leonhardt et al. Sep 1999 A
6010531 Donlon et al. Jan 2000 A
6042607 Williamson, IV et al. Mar 2000 A
6077298 Tu et al. Jun 2000 A
6106550 Magovern et al. Aug 2000 A
6106551 Crossett et al. Aug 2000 A
6132473 Williams et al. Oct 2000 A
6139575 Shu et al. Oct 2000 A
6168614 Andersen et al. Jan 2001 B1
6206911 Milo Mar 2001 B1
6283127 Sterman et al. Sep 2001 B1
6287334 Moll et al. Sep 2001 B1
6299637 Shaolian et al. Oct 2001 B1
6312447 Grimes Nov 2001 B1
6355030 Aldrich et al. Mar 2002 B1
6364904 Smith et al. Apr 2002 B1
6402780 Williamson, IV et al. Jun 2002 B2
6419696 Ortiz et al. Jul 2002 B1
6425916 Garrison et al. Jul 2002 B1
6440164 DiMatteo et al. Aug 2002 B1
6451054 Stevens Sep 2002 B1
6454799 Schreck Sep 2002 B1
6458153 Bailey et al. Oct 2002 B1
6461366 Seguin Oct 2002 B1
6482228 Norred Nov 2002 B1
6503272 Duerig et al. Jan 2003 B2
6508833 Pavcnik et al. Jan 2003 B2
6530952 Vesely Mar 2003 B2
6564805 Garrison et al. May 2003 B2
6569196 Vesely May 2003 B1
6582462 Andersen et al. Jun 2003 B1
6602286 Strecker Aug 2003 B1
6629534 St. Goar et al. Oct 2003 B1
6635085 Caffey et al. Oct 2003 B1
6638239 Bergheim et al. Oct 2003 B1
6652578 Bailey et al. Nov 2003 B2
6666841 Gharib et al. Dec 2003 B2
6666885 Moe Dec 2003 B2
6666886 Tranquillo et al. Dec 2003 B1
6669725 Scott Dec 2003 B2
6673109 Cox Jan 2004 B2
6676698 McGuckin, Jr. et al. Jan 2004 B2
6676702 Mathis Jan 2004 B2
6682558 Tu et al. Jan 2004 B2
6682559 Myers et al. Jan 2004 B2
6685739 DiMatteo et al. Feb 2004 B2
6692512 Jang Feb 2004 B2
6695866 Kuehn et al. Feb 2004 B1
6695878 McGuckin, Jr. et al. Feb 2004 B2
6709456 Langberg et al. Mar 2004 B2
6709457 Otte et al. Mar 2004 B1
6716241 Wilder et al. Apr 2004 B2
6716244 Klaco Apr 2004 B2
6719767 Kimblad Apr 2004 B1
6719784 Henderson Apr 2004 B2
6719786 Ryan et al. Apr 2004 B2
6719787 Cox Apr 2004 B2
6719788 Cox Apr 2004 B2
6719789 Cox Apr 2004 B2
6719790 Brendzel et al. Apr 2004 B2
6723038 Schroeder et al. Apr 2004 B1
6723122 Yang et al. Apr 2004 B2
6723123 Kazatchkov et al. Apr 2004 B1
6726715 Sutherland Apr 2004 B2
6726716 Marquez Apr 2004 B2
6726717 Alfieri et al. Apr 2004 B2
6730118 Spenser et al. May 2004 B2
6730121 Ortiz et al. May 2004 B2
6730122 Pan et al. May 2004 B1
6736791 Tu et al. May 2004 B1
6736845 Marquez et al. May 2004 B2
6736846 Cox May 2004 B2
6749630 McCarthy et al. Jun 2004 B2
6752813 Goldfarb et al. Jun 2004 B2
6752828 Thornton Jun 2004 B2
6755857 Peterson et al. Jun 2004 B2
6761734 Suhr Jul 2004 B2
6761735 Eberhardt et al. Jul 2004 B2
6764494 Menz et al. Jul 2004 B2
6764508 Roehe et al. Jul 2004 B1
6764509 Chinn et al. Jul 2004 B2
6764510 Vidlund et al. Jul 2004 B2
6767362 Schreck Jul 2004 B2
6769434 Liddicoat et al. Aug 2004 B2
6770083 Seguin Aug 2004 B2
6780164 Bergheim et al. Aug 2004 B2
6780200 Jansen Aug 2004 B2
6786924 Ryan et al. Sep 2004 B2
6786925 Buchanan et al. Sep 2004 B1
6790229 Berreklouw Sep 2004 B1
6790230 Beyersdorf et al. Sep 2004 B2
6790231 Liddicoat et al. Sep 2004 B2
6793673 Kowalsky et al. Sep 2004 B2
6797000 Simpson et al. Sep 2004 B2
6797001 Mathis et al. Sep 2004 B2
6797002 Spence et al. Sep 2004 B2
6802860 Cosgrove et al. Oct 2004 B2
6805710 Bolling et al. Oct 2004 B2
6805711 Quijano et al. Oct 2004 B2
6810882 Langberg et al. Nov 2004 B2
6821297 Snyders Nov 2004 B2
6824562 Mathis et al. Nov 2004 B2
6830584 Seguin Dec 2004 B1
6830585 Artof et al. Dec 2004 B1
6837902 Nguyen et al. Jan 2005 B2
6840246 Downing Jan 2005 B2
6840957 DiMatteo et al. Jan 2005 B2
6846324 Stobie Jan 2005 B2
6846325 Liddicoat Jan 2005 B2
6858039 McCarthy Feb 2005 B2
6860895 Akerfeldt et al. Mar 2005 B1
6869444 Gabbay Mar 2005 B2
6872226 Cali Mar 2005 B2
6875224 Grimes Apr 2005 B2
6875230 Morita et al. Apr 2005 B1
6875231 Anduiza et al. Apr 2005 B2
6881199 Wilk et al. Apr 2005 B2
6881224 Kruse et al. Apr 2005 B2
6883522 Spence et al. Apr 2005 B2
6890350 Walak May 2005 B1
6890352 Lentell May 2005 B1
6890353 Cohn et al. May 2005 B2
6893459 Macoviak May 2005 B1
6893460 Spenser et al. May 2005 B2
6896690 Lambrecht et al. May 2005 B1
6896700 Lu et al. May 2005 B2
6902576 Drasler et al. Jun 2005 B2
6908478 Alferness et al. Jun 2005 B2
6908481 Cribier Jun 2005 B2
6911043 Myers et al. Jun 2005 B2
6913608 Liddicoat et al. Jul 2005 B2
6916338 Speziali Jul 2005 B2
6918917 Nguyen et al. Jul 2005 B1
6921407 Nguyen et al. Jul 2005 B2
6921811 Zamora et al. Jul 2005 B2
6926715 Hauck et al. Aug 2005 B1
6926730 Nguyen et al. Aug 2005 B1
6929653 Strecter Aug 2005 B2
6932838 Schwartz et al. Aug 2005 B2
6936067 Buchanan Aug 2005 B2
6939359 Tu et al. Sep 2005 B2
6942694 Liddicoat et al. Sep 2005 B2
6945957 Freyman Sep 2005 B2
6945978 Hyde Sep 2005 B1
6945996 Sedransk Sep 2005 B2
6945997 Huynh et al. Sep 2005 B2
6949122 Adams et al. Sep 2005 B2
6951571 Srivastava Oct 2005 B1
6951573 Dilling Oct 2005 B1
6955656 Bergheim et al. Oct 2005 B2
6955689 Ryan et al. Oct 2005 B2
6958076 Acosta et al. Oct 2005 B2
6962605 Cosgrove et al. Nov 2005 B2
6964682 Nguyen-Thien-Nhon et al. Nov 2005 B2
6964683 Kowalsky et al. Nov 2005 B2
6964684 Ortiz et al. Nov 2005 B2
6966925 Stobie Nov 2005 B2
6966926 Mathis Nov 2005 B2
6974464 Quijano et al. Dec 2005 B2
6974474 Pavcnik et al. Dec 2005 B2
6974476 McGuckin, Jr. et al. Dec 2005 B2
6976995 Mathis et al. Dec 2005 B2
6979350 Moll et al. Dec 2005 B2
6986775 Morales et al. Jan 2006 B2
6989027 Allen et al. Jan 2006 B2
6989028 Lashinski et al. Jan 2006 B2
6997950 Chawla Feb 2006 B2
6997951 Solem et al. Feb 2006 B2
7001411 Dean Feb 2006 B1
7004176 Lau Feb 2006 B2
7007396 Rudko et al. Mar 2006 B2
7007698 Thornton Mar 2006 B2
7011669 Kimblad Mar 2006 B2
7011681 Vesely Mar 2006 B2
7011682 Lashinski et al. Mar 2006 B2
7018406 Seguin et al. Mar 2006 B2
7018407 Wright et al. Mar 2006 B1
7018408 Bailey et al. Mar 2006 B2
7022134 Quijano et al. Apr 2006 B1
7025780 Gabbay Apr 2006 B2
7033390 Johnson et al. Apr 2006 B2
7037333 Myers et al. May 2006 B2
7037334 Hlavka et al. May 2006 B1
7041128 McGuckin, Jr. et al. May 2006 B2
7041132 Quijano et al. May 2006 B2
7044966 Svanidze et al. May 2006 B2
7044967 Solem et al. May 2006 B1
7048754 Martin et al. May 2006 B2
7048757 Shaknovich May 2006 B2
7052487 Cohn et al. May 2006 B2
7052507 Wakuda et al. May 2006 B2
7063722 Marquez Jun 2006 B2
7066954 Ryan et al. Jun 2006 B2
7070616 Majercak et al. Jul 2006 B2
7077862 Vidlund et al. Jul 2006 B2
7081131 Thornton Jul 2006 B2
7087064 Hyde Aug 2006 B1
7089051 Javerud et al. Aug 2006 B2
7090695 Solem et al. Aug 2006 B2
7101396 Artof et al. Sep 2006 B2
7329279 Haug et al. Feb 2008 B2
7331991 Kheradvar et al. Feb 2008 B2
7470285 Nugent et al. Dec 2008 B2
7967853 Eidenschink et al. Jun 2011 B2
8070800 Lock et al. Dec 2011 B2
8092524 Nugent et al. Jan 2012 B2
8133270 Kheradvar et al. Mar 2012 B2
8318078 Jagger et al. Nov 2012 B2
8348999 Kheradvar et al. Jan 2013 B2
8414645 Dwork et al. Apr 2013 B2
8460366 Rowe Jun 2013 B2
8740976 Tran et al. Jun 2014 B2
8852271 Murray, III et al. Oct 2014 B2
8870949 Rowe Oct 2014 B2
8888843 Khairkhahan et al. Nov 2014 B2
8956404 Börtlein et al. Feb 2015 B2
8998979 Seguin et al. Apr 2015 B2
9023098 Kuehn May 2015 B2
9060856 Seguin et al. Jun 2015 B2
9061119 Le et al. Jun 2015 B2
9072604 Melnick et al. Jul 2015 B1
9119713 Board et al. Sep 2015 B2
9119717 Wang et al. Sep 2015 B2
9132008 Dwork et al. Sep 2015 B2
9295547 Costello et al. Mar 2016 B2
9301839 Stante et al. Apr 2016 B2
9333077 Peter May 2016 B2
9358108 Börtlein et al. Jun 2016 B2
9375312 Weber Jun 2016 B2
9387075 Börtlein et al. Jul 2016 B2
20020026216 Grimes Feb 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020183835 Taylor et al. Dec 2002 A1
20020183838 Liddicoat et al. Dec 2002 A1
20030028247 Cali Feb 2003 A1
20030040792 Gabbay Feb 2003 A1
20030050694 Yang et al. Mar 2003 A1
20030130729 Paniagua et al. Jul 2003 A1
20030199975 Gabbay Oct 2003 A1
20030229394 Ogle et al. Dec 2003 A1
20030229395 Cox Dec 2003 A1
20030236568 Hojeibane et al. Dec 2003 A1
20030236569 Mathis et al. Dec 2003 A1
20040002719 Oz et al. Jan 2004 A1
20040003819 St. Goar et al. Jan 2004 A1
20040010305 Alferness et al. Jan 2004 A1
20040015232 Shu et al. Jan 2004 A1
20040015233 Jansen Jan 2004 A1
20040019374 Hojeibane et al. Jan 2004 A1
20040019377 Taylor et al. Jan 2004 A1
20040019378 Hlavka et al. Jan 2004 A1
20040024447 Haverich Feb 2004 A1
20040024452 Kruse et al. Feb 2004 A1
20040030321 Fangrow, Jr. Feb 2004 A1
20040030381 Shu Feb 2004 A1
20040030382 St. Goar et al. Feb 2004 A1
20040030405 Carpentier et al. Feb 2004 A1
20040034380 Woolfson et al. Feb 2004 A1
20040039436 Spenser et al. Feb 2004 A1
20040039442 St. Goar et al. Feb 2004 A1
20040044350 Martin et al. Mar 2004 A1
20040044365 Bachman Mar 2004 A1
20040044403 Bischoff et al. Mar 2004 A1
20040049207 Goldfarb et al. Mar 2004 A1
20040049211 Tremulis et al. Mar 2004 A1
20040059351 Eigler et al. Mar 2004 A1
20040059411 Strecker Mar 2004 A1
20040059412 Lytle, IV et al. Mar 2004 A1
20040060161 Leal et al. Apr 2004 A1
20040073301 Donlon et al. Apr 2004 A1
20040073302 Rourke et al. Apr 2004 A1
20040078072 Tu et al. Apr 2004 A1
20040078074 Anderson et al. Apr 2004 A1
20040082910 Constantz et al. Apr 2004 A1
20040082923 Field Apr 2004 A1
20040087975 Lucatero et al. May 2004 A1
20040088045 Cox May 2004 A1
20040092858 Wilson et al. May 2004 A1
20040093070 Hojeibane et al. May 2004 A1
20040093080 Helmus et al. May 2004 A1
20040097979 Svanidze et al. May 2004 A1
20040098098 McGuckin, Jr. et al. May 2004 A1
20040102839 Cohn et al. May 2004 A1
20040102840 Solem et al. May 2004 A1
20040106991 Hopkins et al. Jun 2004 A1
20040111096 Tu et al. Jun 2004 A1
20040117009 Cali et al. Jun 2004 A1
20040122448 Levine Jun 2004 A1
20040122512 Navia et al. Jun 2004 A1
20040122513 Navia et al. Jun 2004 A1
20040122514 Fogarty et al. Jun 2004 A1
20040122515 Chu Jun 2004 A1
20040122516 Fogarty et al. Jun 2004 A1
20040127979 Wilson et al. Jul 2004 A1
20040127981 Rahdert et al. Jul 2004 A1
20040127982 Machold et al. Jul 2004 A1
20040133220 Lashinski et al. Jul 2004 A1
20040133267 Lane Jul 2004 A1
20040133273 Cox Jul 2004 A1
20040138744 Lashinski et al. Jul 2004 A1
20040138745 Macoviak et al. Jul 2004 A1
20040148018 Carpentier et al. Jul 2004 A1
20040148019 Vidlund et al. Jul 2004 A1
20040148020 Vidlund et al. Jul 2004 A1
20040153147 Mathis Aug 2004 A1
20040158321 Reuter et al. Aug 2004 A1
20040162610 Liska et al. Aug 2004 A1
20040167539 Kuehn et al. Aug 2004 A1
20040172046 Hlavka et al. Sep 2004 A1
20040176839 Huynh et al. Sep 2004 A1
20040176840 Langberg et al. Sep 2004 A1
20040181238 Zarbatany et al. Sep 2004 A1
20040186444 Daly et al. Sep 2004 A1
20040186558 Pavcnik et al. Sep 2004 A1
20040186563 Lobbi Sep 2004 A1
20040186565 Schreck Sep 2004 A1
20040186566 Hindrichs et al. Sep 2004 A1
20040193191 Starksen et al. Sep 2004 A1
20040193253 Thorpe et al. Sep 2004 A1
20040193260 Alferness et al. Sep 2004 A1
20040199155 Mollenauer Oct 2004 A1
20040199183 Oz et al. Oct 2004 A1
20040199191 Schwartz Oct 2004 A1
20040204758 Eberhardt et al. Oct 2004 A1
20040206363 McCarthy et al. Oct 2004 A1
20040210240 Saint Oct 2004 A1
20040210301 Obermiller Oct 2004 A1
20040210304 Seguin et al. Oct 2004 A1
20040210305 Shu et al. Oct 2004 A1
20040210306 Quijano et al. Oct 2004 A1
20040210307 Khairkhahan Oct 2004 A1
20040215333 Duran et al. Oct 2004 A1
20040215339 Drasler et al. Oct 2004 A1
20040220654 Mathis et al. Nov 2004 A1
20040220657 Nieminen et al. Nov 2004 A1
20040225322 Garrison et al. Nov 2004 A1
20040225344 Hoffa et al. Nov 2004 A1
20040225348 Case et al. Nov 2004 A1
20040225352 Osborne et al. Nov 2004 A1
20040225355 Stevens Nov 2004 A1
20040225356 Frater Nov 2004 A1
20040230117 Tosaya et al. Nov 2004 A1
20040236411 Sarac et al. Nov 2004 A1
20040236418 Stevens Nov 2004 A1
20040236419 Milo Nov 2004 A1
20040243153 Liddicoat et al. Dec 2004 A1
20040243219 Fischer et al. Dec 2004 A1
20040243227 Starksen et al. Dec 2004 A1
20040243230 Navia et al. Dec 2004 A1
20040254600 Zarbatany et al. Dec 2004 A1
20040254636 Flagle et al. Dec 2004 A1
20040260276 Rudko et al. Dec 2004 A1
20040260317 Bloom et al. Dec 2004 A1
20040260322 Rudko et al. Dec 2004 A1
20040260389 Case et al. Dec 2004 A1
20040260390 Sarac et al. Dec 2004 A1
20040260393 Rahdert et al. Dec 2004 A1
20040260394 Douk et al. Dec 2004 A1
20040267357 Allen et al. Dec 2004 A1
20050004583 Oz et al. Jan 2005 A1
20050004667 Swinford et al. Jan 2005 A1
20050004668 Aklog et al. Jan 2005 A1
20050010285 Lambrecht et al. Jan 2005 A1
20050010287 Macoviak et al. Jan 2005 A1
20050015112 Cohn et al. Jan 2005 A1
20050021056 St. Goar et al. Jan 2005 A1
20050021136 Xie et al. Jan 2005 A1
20050027261 Wever et al. Feb 2005 A1
20050027348 Case et al. Feb 2005 A1
20050027351 Reuter et al. Feb 2005 A1
20050027353 Alferness et al. Feb 2005 A1
20050033398 Seguin Feb 2005 A1
20050033419 Alferness et al. Feb 2005 A1
20050033446 Deem et al. Feb 2005 A1
20050038506 Webler et al. Feb 2005 A1
20050038507 Alferness et al. Feb 2005 A1
20050043792 Solem et al. Feb 2005 A1
20050049679 Taylor et al. Mar 2005 A1
20050049692 Numamoto et al. Mar 2005 A1
20050049696 Siess et al. Mar 2005 A1
20050049697 Sievers Mar 2005 A1
20050054977 Laird et al. Mar 2005 A1
20050055079 Duran Mar 2005 A1
20050055087 Starksen Mar 2005 A1
20050055088 Liddicoat et al. Mar 2005 A1
20050055089 Macoviak et al. Mar 2005 A1
20050060029 Le et al. Mar 2005 A1
20050060030 Lashinski et al. Mar 2005 A1
20050065460 Laird Mar 2005 A1
20050065550 Starksen et al. Mar 2005 A1
20050065594 DiMatteo et al. Mar 2005 A1
20050065597 Lansac Mar 2005 A1
20050070906 Clark et al. Mar 2005 A1
20050070998 Rourke et al. Mar 2005 A1
20050075584 Cali Apr 2005 A1
20050075659 Realyvasquez et al. Apr 2005 A1
20050075662 Pedersen et al. Apr 2005 A1
20050075712 Biancucci et al. Apr 2005 A1
20050075713 Biancucci et al. Apr 2005 A1
20050075717 Nguyen et al. Apr 2005 A1
20050075718 Nguyen et al. Apr 2005 A1
20050075719 Bergheim Apr 2005 A1
20050075720 Nguyen et al. Apr 2005 A1
20050075723 Schroeder et al. Apr 2005 A1
20050075724 Svanidze et al. Apr 2005 A1
20050075725 Rowe Apr 2005 A1
20050075729 Nguyen et al. Apr 2005 A1
20050075730 Myers et al. Apr 2005 A1
20050080483 Solem et al. Apr 2005 A1
20050085900 Case et al. Apr 2005 A1
20050085904 Lemmon Apr 2005 A1
20050090846 Pedersen et al. Apr 2005 A1
20050096735 Hojeibane et al. May 2005 A1
20050096738 Cali et al. May 2005 A1
20050096739 Cao May 2005 A1
20050096740 Langberg et al. May 2005 A1
20050101975 Nguyen et al. May 2005 A1
20050101988 Stanford et al. May 2005 A1
20050102026 Turner et al. May 2005 A1
20050107810 Morales et al. May 2005 A1
20050107811 Starksen et al. May 2005 A1
20050107812 Starksen et al. May 2005 A1
20050107872 Mensah et al. May 2005 A1
20050113910 Paniagua et al. May 2005 A1
20050119673 Gordon et al. Jun 2005 A1
20050119734 Spence et al. Jun 2005 A1
20050119735 Spence et al. Jun 2005 A1
20050125011 Spence et al. Jun 2005 A1
20050131438 Cohn Jun 2005 A1
20050131533 Alfieri et al. Jun 2005 A1
20050137449 Nieminen et al. Jun 2005 A1
20050137450 Aronson et al. Jun 2005 A1
20050137451 Gordon et al. Jun 2005 A1
20050137676 Richardson et al. Jun 2005 A1
20050137681 Shoemaker et al. Jun 2005 A1
20050137682 Justino Jun 2005 A1
20050137685 Nieminen et al. Jun 2005 A1
20050137686 Salahieh et al. Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137689 Salahieh et al. Jun 2005 A1
20050137690 Salahieh et al. Jun 2005 A1
20050137691 Salahieh et al. Jun 2005 A1
20050137692 Haug et al. Jun 2005 A1
20050137694 Haug et al. Jun 2005 A1
20050137696 Salahieh et al. Jun 2005 A1
20050137697 Salahieh et al. Jun 2005 A1
20050137698 Salahieh et al. Jun 2005 A1
20050137699 Salahieh et al. Jun 2005 A1
20050137700 Spence et al. Jun 2005 A1
20050137701 Salahieh et al. Jun 2005 A1
20050137702 Haug et al. Jun 2005 A1
20050143807 Pavcnik et al. Jun 2005 A1
20050143809 Salahieh et al. Jun 2005 A1
20050143810 Dauner et al. Jun 2005 A1
20050143811 Realyvasquez Jun 2005 A1
20050149014 Hauck et al. Jul 2005 A1
20050149179 Mathis et al. Jul 2005 A1
20050149180 Mathis et al. Jul 2005 A1
20050149181 Eberhardt Jul 2005 A1
20050154442 Eidenschink et al. Jul 2005 A1
20050159810 Filsoufi Jul 2005 A1
20050159811 Lane Jul 2005 A1
20050165477 Anduiza et al. Jul 2005 A1
20050165478 Song Jul 2005 A1
20050171472 Lutter Aug 2005 A1
20050171601 Cosgrove et al. Aug 2005 A1
20050177227 Heim et al. Aug 2005 A1
20050177228 Solem et al. Aug 2005 A1
20050182483 Osborne et al. Aug 2005 A1
20050184122 Hlavka et al. Aug 2005 A1
20050187614 Agnew Aug 2005 A1
20050187616 Realyvasquez Aug 2005 A1
20050187617 Navia Aug 2005 A1
20050192606 Paul, Jr. et al. Sep 2005 A1
20050192665 Spenser et al. Sep 2005 A1
20050197692 Pai et al. Sep 2005 A1
20050197693 Pai et al. Sep 2005 A1
20050197694 Pai et al. Sep 2005 A1
20050203549 Realyvasquez Sep 2005 A1
20050203605 Dolan Sep 2005 A1
20050203614 Forster et al. Sep 2005 A1
20050203615 Forster et al. Sep 2005 A1
20050203616 Cribier Sep 2005 A1
20050203617 Forster et al. Sep 2005 A1
20050203618 Sharkawy et al. Sep 2005 A1
20050216039 Lederman Sep 2005 A1
20050216077 Mathis et al. Sep 2005 A1
20050216078 Starksen et al. Sep 2005 A1
20050222675 Sauter Oct 2005 A1
20050222678 Lashinski et al. Oct 2005 A1
20050228422 Machold et al. Oct 2005 A1
20050228479 Pavcnik et al. Oct 2005 A1
20050228486 Case et al. Oct 2005 A1
20050228494 Marquez Oct 2005 A1
20050228495 Macoviak Oct 2005 A1
20050228496 Mensah et al. Oct 2005 A1
20050234541 Hunt et al. Oct 2005 A1
20050234546 Nugent et al. Oct 2005 A1
20050240200 Bergheim Oct 2005 A1
20050240202 Shennib et al. Oct 2005 A1
20050240255 Schaeffer Oct 2005 A1
20050240259 Sisken et al. Oct 2005 A1
20050240262 White Oct 2005 A1
20050244460 Alferiev et al. Nov 2005 A1
20050246013 Gabbay Nov 2005 A1
20050251251 Cribier Nov 2005 A1
20050256566 Gabbay Nov 2005 A1
20050261704 Mathis Nov 2005 A1
20050261759 Lambrecht et al. Nov 2005 A1
20050267493 Schreck et al. Dec 2005 A1
20050267560 Bates Dec 2005 A1
20050267565 Dave et al. Dec 2005 A1
20050267571 Spence et al. Dec 2005 A1
20050267573 Macoviak et al. Dec 2005 A9
20050267574 Cohn et al. Dec 2005 A1
20050272969 Alferness et al. Dec 2005 A1
20050273160 Lashinski et al. Dec 2005 A1
20050278015 Dave et al. Dec 2005 A1
20050283178 Flagle et al. Dec 2005 A1
20050283231 Haug et al. Dec 2005 A1
20050288779 Shaoulian et al. Dec 2005 A1
20060000715 Whitcher et al. Jan 2006 A1
20060004439 Spenser et al. Jan 2006 A1
20060004442 Spenser et al. Jan 2006 A1
20060009841 McGuckin et al. Jan 2006 A1
20060009842 Huynh et al. Jan 2006 A1
20060013805 Hebbel et al. Jan 2006 A1
20060013855 Carpenter et al. Jan 2006 A1
20060015136 Besselink Jan 2006 A1
20060015178 Moaddeb et al. Jan 2006 A1
20060015179 Bulman-Fleming et al. Jan 2006 A1
20060020275 Goldfarb et al. Jan 2006 A1
20060020327 Lashinski et al. Jan 2006 A1
20060020332 Lashinski et al. Jan 2006 A1
20060020334 Lashinski et al. Jan 2006 A1
20060020335 Kowalsky et al. Jan 2006 A1
20060020336 Liddicoat Jan 2006 A1
20060025750 Starksen et al. Feb 2006 A1
20060025784 Starksen et al. Feb 2006 A1
20060025787 Morales et al. Feb 2006 A1
20060025854 Lashinski et al. Feb 2006 A1
20060025855 Lashinski et al. Feb 2006 A1
20060025856 Ryan et al. Feb 2006 A1
20060025857 Bergheim et al. Feb 2006 A1
20060030747 Kantrowitz et al. Feb 2006 A1
20060030866 Schreck Feb 2006 A1
20060030882 Adams et al. Feb 2006 A1
20060030885 Hyde Feb 2006 A1
20060036317 Vidlund et al. Feb 2006 A1
20060041305 Lauterjung Feb 2006 A1
20060041306 Vidlund et al. Feb 2006 A1
20060047297 Case Mar 2006 A1
20060047338 Jenson et al. Mar 2006 A1
20060047343 Oviatt et al. Mar 2006 A1
20060052804 Mlalhle Mar 2006 A1
20060052867 Reveulta et al. Mar 2006 A1
20060058817 Starksen et al. Mar 2006 A1
20060058865 Case et al. Mar 2006 A1
20060058871 Zakay et al. Mar 2006 A1
20060058889 Case et al. Mar 2006 A1
20060064115 Allen et al. Mar 2006 A1
20060064116 Allen et al. Mar 2006 A1
20060064118 Kimblad Mar 2006 A1
20060064174 Zadno Mar 2006 A1
20060069400 Burnett et al. Mar 2006 A1
20060069430 Rahdert et al. Mar 2006 A9
20060074483 Schrayer Apr 2006 A1
20060074484 Huber Apr 2006 A1
20060074485 Realyvasquez Apr 2006 A1
20060085060 Campbell Apr 2006 A1
20060089708 Osse et al. Apr 2006 A1
20060095115 Biadillah et al. May 2006 A1
20060095125 Chinn et al. May 2006 A1
20060099326 Keogh et al. May 2006 A1
20060100687 Fahey et al. May 2006 A1
20060100697 Casanova May 2006 A1
20060100699 Vidlund et al. May 2006 A1
20060106278 Machold et al. May 2006 A1
20060106279 Machold et al. May 2006 A1
20060106456 Machold et al. May 2006 A9
20060111660 Wolf et al. May 2006 A1
20060111773 Rittgers et al. May 2006 A1
20060111774 Samkov et al. May 2006 A1
20060116572 Case Jun 2006 A1
20060116756 Solem et al. Jun 2006 A1
20060122686 Gilad et al. Jun 2006 A1
20060122692 Gilad et al. Jun 2006 A1
20060122693 Biadillah et al. Jun 2006 A1
20060127443 Helmus Jun 2006 A1
20060129235 Seguin et al. Jun 2006 A1
20060129236 McCarthy Jun 2006 A1
20060135476 Kutryk et al. Jun 2006 A1
20060135964 Vesely Jun 2006 A1
20060135967 Realyvasquez Jun 2006 A1
20060136044 Osborne et al. Jun 2006 A1
20060136045 Flagle et al. Jun 2006 A1
20060136052 Vesely Jun 2006 A1
20060136054 Berg et al. Jun 2006 A1
20060142848 Gabbay Jun 2006 A1
20060149358 Zilla et al. Jul 2006 A1
20060149360 Schwammenthal et al. Jul 2006 A1
20060149367 Sieracki Jul 2006 A1
20060149368 Spence Jul 2006 A1
20060161248 Case et al. Jul 2006 A1
20060161250 Shaw Jul 2006 A1
20060167468 Gabbay Jul 2006 A1
20060167541 Lattouf Jul 2006 A1
20060167542 Quintessenza Jul 2006 A1
20060167543 Bailey et al. Jul 2006 A1
20060216173 Kheradvar et al. Sep 2006 A1
20060235511 Osborne Oct 2006 A1
20060282157 Hill et al. Dec 2006 A1
20070112355 Salahieh et al. May 2007 A1
20070168024 Khairkhahan Jul 2007 A1
20070239255 Hines Oct 2007 A1
20070255423 Carpentier et al. Nov 2007 A1
20070282371 Lee et al. Dec 2007 A1
20070293935 Olsen et al. Dec 2007 A1
20070299499 Hartley et al. Dec 2007 A1
20080029296 Brist et al. Feb 2008 A1
20080039863 Keegan et al. Feb 2008 A1
20080071364 Kaye et al. Mar 2008 A1
20080161909 Kheradvar et al. Jul 2008 A1
20080275550 Kheradvar et al. Nov 2008 A1
20090030497 Metcalf et al. Jan 2009 A1
20090082857 Lashinski et al. Mar 2009 A1
20090099640 Weng Apr 2009 A1
20090192585 Bloom et al. Jul 2009 A1
20100175693 Wondka et al. Jul 2010 A1
20110040366 Goetz et al. Feb 2011 A1
20110040374 Goetz et al. Feb 2011 A1
20110112622 Phan et al. May 2011 A1
20110196472 Sugimoto et al. Aug 2011 A1
20110251664 Acosta De Acevedo Oct 2011 A1
20130046373 Cartledge et al. Feb 2013 A1
20130204356 Dwork et al. Aug 2013 A1
20140100651 Kheradvar et al. Apr 2014 A1
20140128963 Quill et al. May 2014 A1
20140236392 Nanba Aug 2014 A1
20140296970 Ekvall et al. Oct 2014 A1
20140296972 Tegels et al. Oct 2014 A1
20150112430 Creaven et al. Apr 2015 A1
20150196393 Vidlund et al. Jul 2015 A1
20150257882 Börtlein et al. Sep 2015 A1
20150272730 Melnick et al. Oct 2015 A1
20150297346 Duffy et al. Oct 2015 A1
20150327999 Board et al. Nov 2015 A1
20160038281 Delaloye et al. Feb 2016 A1
20160120643 Kupumbati May 2016 A1
20160220363 Peter Aug 2016 A1
Foreign Referenced Citations (85)
Number Date Country
0380686 Aug 1990 EP
0466518 Jan 1992 EP
0667133 Mar 2001 EP
WO 9015582 Dec 1990 WO
WO 9501669 Jan 1995 WO
WO 9619159 Jun 1996 WO
WO 8800459 Jan 1998 WO
WO 9803656 Jan 1998 WO
WO 9846115 Oct 1998 WO
WO 9904724 Feb 1999 WO
WO 0047139 Aug 2000 WO
WO 0067679 Nov 2000 WO
WO 0115650 Mar 2001 WO
WO 0117462 Mar 2001 WO
WO 0154624 Aug 2001 WO
WO 2004043265 May 2004 WO
WO 2004043273 May 2004 WO
WO 2004043293 May 2004 WO
WO 2004045378 Jun 2004 WO
WO 2004062725 Jul 2004 WO
WO 2004066803 Aug 2004 WO
WO 2004066826 Aug 2004 WO
WO 2004075789 Sep 2004 WO
WO 2004082528 Sep 2004 WO
WO 2004082536 Sep 2004 WO
WO 2004082537 Sep 2004 WO
WO 2004084746 Oct 2004 WO
WO 2004084770 Oct 2004 WO
WO 2004089250 Oct 2004 WO
WO 2004089253 Oct 2004 WO
WO 2004093638 Nov 2004 WO
WO 2004103222 Dec 2004 WO
WO 2004105584 Dec 2004 WO
WO 2004112582 Dec 2004 WO
WO 2004112585 Dec 2004 WO
WO 2004112652 Dec 2004 WO
WO 2005000152 Jan 2005 WO
WO 2005002466 Jan 2005 WO
WO 2005004753 Jan 2005 WO
WO 2005007018 Jan 2005 WO
WO 2005007036 Jan 2005 WO
WO 2005007037 Jan 2005 WO
WO 2005009285 Feb 2005 WO
WO 2005011473 Feb 2005 WO
WO 2005027790 Mar 2005 WO
WO 2005027797 Mar 2005 WO
WO 2005039428 May 2005 WO
WO 2005039452 May 2005 WO
WO 2005046488 May 2005 WO
WO 2005046528 May 2005 WO
WO 2005046530 May 2005 WO
WO 2005055883 Jun 2005 WO
WO 2005058206 Jun 2005 WO
WO 2005070342 Aug 2005 WO
WO 2005070343 Aug 2005 WO
WO 2005072654 Aug 2005 WO
WO 2005072655 Aug 2005 WO
WO 2005079706 Sep 2005 WO
WO 2005087139 Sep 2005 WO
WO 2005087140 Sep 2005 WO
WO 2006000763 Jan 2006 WO
WO 2006002492 Jan 2006 WO
WO 2006004679 Jan 2006 WO
WO 2006011127 Feb 2006 WO
WO 2006026912 Mar 2006 WO
WO 2006027499 Mar 2006 WO
WO 2006028821 Mar 2006 WO
WO 2006034245 Mar 2006 WO
WO 2006048664 May 2006 WO
WO 2006050460 May 2006 WO
WO 2006054107 May 2006 WO
WO 2006054930 May 2006 WO
WO 2006055982 May 2006 WO
WO 2006063108 Jun 2006 WO
WO 2006063181 Jun 2006 WO
WO 2006063199 Jun 2006 WO
WO 2006064490 Jun 2006 WO
WO 2006065212 Jun 2006 WO
WO 2006065930 Jun 2006 WO
WO 2006066148 Jun 2006 WO
WO 2006066150 Jun 2006 WO
WO 2006069094 Jun 2006 WO
WO 2006076890 Jul 2006 WO
WO 2013022798 Feb 2013 WO
WO 2013155474 Oct 2013 WO
Non-Patent Literature Citations (54)
Entry
EP, 14763413.3 Extended Search Report, Sep. 29, 2016.
WO, PCT/US2006/07022 ISR, Mar. 10, 2008.
WO, PCT/US2008/000277 ISR, Jun. 23, 2008.
WO, PCT/US2008/001321 ISR, Jul. 28, 2008.
WO, PCT/US2012/049645 ISR, Jan. 2, 2013.
WO, PCT/US2013/036469 ISR, Jul. 29, 2013.
WO, PCT/US2006/07022 IPRP, Mar. 3, 2009.
WO, PCT/US2008/000277 IPRP, Jul. 14, 2009.
WO, PCT/US2008/001321 IPRP, Aug. 4, 2009.
WO, PCT/US2012/049645 IPRP, Feb. 11, 2014.
Bagur, R., et al., “Usefulness of TEE as the Primary Imaging Technique to Guide Transcatheter Transapical Aortic Valve Implantation”, JACC: Cardiovascular Imaging, 2011, vol. 4, No. 2, pp. 115-124.
Buzzatti, N., et al., “Computed tomography-based evaluation of aortic annulus, prosthesis size and impact on early residual aortic regurgitation after transcatheter aortic valve implantation”, European Journal of Cardio-Thoracic Surgery, 2013, vol. 43, pp. 43-51.
Cribier, A., et al., “Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description”, Circulation, 2002, vol. 106, pp. 3006-3008.
De Heer, L. M., et al., “Multimodality imaging throughout transcatheter aortic valve implantation”, Future Cardiology, 2012, vol. 8, No. 3, pp. 413-424.
Dumont, E., et al., “Feasibility of transapical aortic valve implantation fully guided by transesophageal echocardiography”, J. Thoracic and Cardiovasc. Surgery, 2009, vol. 138, pp. 1022-1024.
Elgort, D.R., et al., “Image-Guided and-Monitored Renal Artery Stenting Using Only MRI”, J. Magn. Reson. Imaging, 2006, vol. 23, No. 5, pp. 619-627.
Falahatpisheh, A., et al., “High-speed particle image velocimetry to assess cardiac fluid dynamics in vitro: From performance to validation”, European Journal of Mechanics—B/Fluids, 2012, vol. 35, pp. 2-8.
Ferrari, E., et al., “Imaging for trans-catheter pulmonary stent-valve implantation without angiography: role of intravascular ultrasound”, European Journal of Cardio-thoracic Surgery, 2011, vol. 40, pp. 522-524.
Geisbüsch, S., et al., “Incidence and Management of CoreValve Dislocation During Transcatheter Aortic Valve Implantation”, Circ. Cardiovasc. Interv., 2010, vol. 3, pp. 531-536.
Giri, J., et al., “Procedural and Clinical Outcomes of the Valve-in-Valve Technique for Severe Aortic Insufficiency after Balloon-Expandable Transcatheter Aortic Valve Replacement”, Catheterization and Cardiovascular Interventions, 2012, vol. 80, No. 1, pp. 139-147.
Groves, E. M., et al., “The Effects of Positioning of Transcatheter Aortic Valves on Fluid Dynamics of the Aortic Root”, ASAIO Journal 2014, pp. 545-552.
Gurvitch, R., et al., “Transcatheter Valve-in-Valve Implantation for Failed Surgical Bioprosthetic Valves”, J. Am. Coll. Cardiol., 2011, vol. 58, No. 21, pp. 2196-2209.
Jánosi, R. A., et al., “Guidance of percutaneous transcatheter aortic valve implantation by real-time three-dimensional transesophageal echocardiography—A single-center experience”, Minimally Invasive Therapy & Allied Technologies, 2009, vol. 18, No. 3, pp. 142-148.
Kahlert, P., et al., “Towards real-time cardiovascular magnetic resonance guided transarterial CoreValve implantation: in vivo evaluation in swine”, Journal of Cardiovascular Magnetic Resonance, 2012, vol. 14, No. 21, pp. 1-15.
Kapadia, S. R., et al., “Imaging for Transcatheter Valve Procedures”, Current Problems in Cardiology, 2010, vol. 35, No. 5, pp. 228-276.
Kawase, Y., et al., “In Vivo Volumetric Analysis of Coronary Stent Using Optical Coherence Tomography With a Novel Balloon Occlusion-Flushing Catheter: A Comparison With Intravascular Ultrasound”, Ultrasound in Medicine and Biology, 2005, vol. 31, No. 10, pp. 1343-1349.
Kempfert, J., et al., “Aortic annulus sizing: echocardiographic versus computed tomography derived measurements in comparison with direct surgical sizing”, European Journal of Cardio-Thoracic Surgery, 2012, vol. 42, pp. 627-633.
Kheradvar, A., et al., “An in Vitro Study of Changing Profile Heights in Mitral Bioprostheses and Their Influence on Flow”, ASAIO Journal, 2006, vol. 52, pp. 34-38.
Kheradvar, A., et al., “Correlation Between Vortex Ring Formation and Mitral Annulus Dynamics During Ventricular Rapid Filling”, ASAIO Journal, 2007, vol. 53, pp. 8-16.
Kheradvar, A., et al., “On Mitral Valve Dynamics and its Connection to Early Diastolic Flow”, Ann. Biomed. Eng., 2009, vol. 37, No. 1, pp. 1-13.
Koos, R., et al., “Prevalence and Clinical Importance of Aortic Valve Calcification Detected Incidentally on CT Scans: Comparison with Echocardiography”, Radiology, 2006, vol. 241, No. 1, pp. 76-82.
Kpodonu, J., et al., “Intravascular Ultrasound Imaging as Applied to the Aorta: A New Tool for the Cardiovascular Surgeon”, Ann. Thorac. Surg., 2008, vol. 86, No. 4, pp. 1391-1398.
Leon, M. B., et al., “Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery”, The New England Journal of Medicine, 2010, vol. 363, No. 17, pp. 1597-1607.
Mack, M. J., et al., “Does Transcatheter Aortic Valve Implantation Mean the End of Surgical Aortic Valve Replacement?”, Tex Heart Inst J., 2010, vol. 37, No. 6, pp. 658-659.
Makkar, R. R., et al., “Transcatheter Aortic-Valve Replacement for Inoperable Severe Aortic Stenosis”, The New England Journal of Medicine, 2012, vol. 366, pp. 1696-1704.
Mintz, G. S., et al., “American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS)—A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents”, Journal of the American College of Cardiology, 2001, vol. 37, No. 5, pp. 1478-1492.
Moraveji, J., et al., “Computational Modeling of Nitinol Stents for Percutaneous Heart Valves”, ASAIO Journal, ASAIO Cardiopulmonary Abstracts, 2010, vol. 56, No. 2, pp. 93.
Moss, R. R., et al., “Role of Echocardiography in Percutaneous Aortic Valve Implantation”, JACC: Cardiovascular Imaging, 2008, vol. 1, No. 1, pp. 15-24.
Naqvi, T. Z., “Echocardiography in Percutaneous Valve Therapy”, JACC: Cardiovascular Imaging, 2009, vol. 2, No. 10, pp. 1226-1237.
Piazza, N., et al., “Implantation of Two Self-Expanding Aortic Bioprosthetic Valves During the Same Procedure—Insights into Valve-in-Valve Implantation (“Russian Doll Concept”)”, Catheterization and Cardiovascular Interventions, 2009, vol. 73, No. 4, pp. 530-539.
Rodés-Cabau, J., “Progress in Transcatheter Aortic Valve Implantation”, Rev Esp Cardiol., 2010, vol. 63, No. 4, pp. 439-450.
Ruiz, C. E., et al., “First Percutaneous Transcatheter Aortic Valve-in-Valve Implant With Three Year Follow-Up”, Catheterization and Cardiovascular Interventions, 2008, vol. 72, No. 2, pp. 143-148.
Sarkar, K., et al., “Core Valve Embolization: Technical Challenges and Management”, Catheterization and Cardiovascular Interventions, 2012, vol. 79, No. 5, pp. 777-782.
Su, J. L., et al., “Photoacoustic imaging of coronary artery stents”, Optics Express, 2009, vol. 17, No. 22, pp. 19894-19901.
Thielmann, M., et al., “Current developments in transcatheter aortic, valve implantation techniques”, Herz, 2011, vol. 36, No. 8, pp. 696-705.
Thomas, M., et al., “Thirty-Day Results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry A European Registry of Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Valve”, Circulation, 2010, vol. 122, pp. 62-69.
Treede, H., et al., “Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: The Direct Flow Medical aortic valve”, J. Thoracic and Cardiovasc. Surg., 2010, vol. 140, No. 4, pp. 897-903.
Treede, H., et al., “Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicentre CE-mark study”, European Journal of Cardio-Thoracic Surgery, 2012, pp. 1-8.
Ussia, G. P., et al., “Management of Implant Failure During Transcatheter Aortic Valve Implantation”, Catheterization and Cardiovascular Interventions, 2010, vol. 76, No. 3, pp. 440-449.
Ussia, G. P., et al., “The Valve-in-Valve Technique for Treatment of Aortic Bioprosthesis Malposition, An Analysis of Incidence and 1-Year Clinical Outcomes From the Italian CoreValve Registry”, J. Am. Coll. of Cardiology, 2011, vol. 57, No. 9, pp. 1062-1068.
Webb, J. G., et al., “Transcatheter Valve-in-Valve Implantation for Failed Bioprosthetic Heart Valves”, Circulation, 2010, vol. 121, pp. 1848-1857.
WO, PCT/US2014/028576 ISR, Jul. 1, 2014.
WO, PCT/US2014/028576 IPRP, Sep. 15, 2015.
CN, 201380031016.2 Second Office Action, Apr. 18, 2016.
Related Publications (1)
Number Date Country
20140316518 A1 Oct 2014 US
Provisional Applications (1)
Number Date Country
61793926 Mar 2013 US